The Significance of Early Alpha-Fetoprotein Level Changes in Predicting Clinical and Survival Benefits in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib

BACKGROUND. The role of serum alpha-fetoprotein (AFP) changes in predicting the treatment outcomes of advanced hepatocellular carcinoma (HCC) patients to sorafenib remains unknown. METHODS. Serum AFP was collected prospectively at baseline and subsequent follow-up visits in parallel with clinical an...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Yau, Thomas, Yao, T.J., Chan, Pierre, Wong, Hilda, Pang, Roberta, Fan, Sheung Tat, Poon, Ronnie T.P.
Format: Artigo
Idioma:Inglês
Publicat: AlphaMed Press 2011
Matèries:
Hepatobiliary
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3228178/
https://ncbi.nlm.nih.gov/pubmed/21885876
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2011-0105
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars